Future Landscape of Anti-Claudin 18.2 Antibodies in Gastric Adenocarcinoma
Advanced gastric adenocarcinoma (GAC) carries a poor prognosis. Targeted therapy in GAC has traditionally been limited to anti-human epidermal growth factor receptor-2 and anti-vascular endothelial growth factor agents. Recent years have brought immune checkpoint therapy to the GAC treatment landsca...
| Published in: | Antibodies |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4468/14/1/26 |